Review of the Safety and Efficacy of Moringa oleifera.
Level 5 - mechanism / opinion, no new human data
Narrative literature review synthesizing preclinical models and limited human trials without systematic review methodology.
PubMed 25808883 · doi:10.1002/ptr.5325
What was done
The authors conducted a narrative review summarizing published literature on the safety, chemical constituents, and biological efficacy of Moringa oleifera plant parts (leaves, seeds, bark, roots, sap, and flowers). The review synthesizes findings from animal safety/pharmacology models and five published clinical studies evaluating powdered whole leaf preparations in humans.
What was found
Animal safety studies of aqueous leaf extracts indicated a high degree of safety, and human studies reported no adverse effects. Five human studies using powdered whole leaf preparations demonstrated anti-hyperglycemic (antidiabetic) and anti-dyslipidemic activities, consistent with animal findings. Preclinical studies also demonstrated antioxidant, tissue-protective (liver, kidneys, heart, testes, lungs), analgesic, antiulcer, antihypertensive, radioprotective, and immunomodulatory properties. The abstract provides no specific numerical values or effect sizes.
Why it matters
This review highlights the potential of Moringa oleifera as a supportive therapeutic agent for metabolic conditions while emphasizing that clinical translation requires addressing significant inconsistencies in product standardization.
Limits
The review lacks systematic search methodology and quantitative meta-analysis. Clinical evidence is limited to only five human studies, for which sample sizes, study designs, controls, and dosages are not specified in the abstract. Most reported biological activities rely entirely on preclinical animal or in vitro models.
Cited by
- supports Moringa leaves and moringa leaf powder have a documented history of safe human dietary consumption over centuries across tropical regions.